RPS29 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL24176574	1.00	14/20
SCHEMBL16189192	0.69	12/20
SCHEMBL21598983	0.65	11/20
SCHEMBL21599020	0.65	11/20
SCHEMBL16189119	0.68	10/20
SCHEMBL16177128	1.00	9/20
SCHEMBL16177345	1.00	9/20
SCHEMBL16177805	1.00	9/20
SCHEMBL16177066	0.74	9/20
SCHEMBL16177239	0.74	9/20
SCHEMBL16177254	0.73	9/20
SCHEMBL17536518	0.68	9/20
SCHEMBL17536553	0.66	9/20
SCHEMBL17536517	0.66	9/20
SCHEMBL17536519	0.64	9/20
SCHEMBL24176583	0.64	9/20
SCHEMBL17536554	0.62	9/20
SCHEMBL21598955	0.54	9/20
SCHEMBL21599023	0.54	9/20
SCHEMBL21598989	0.52	9/20

Clinical trials — most relevant to RPS29 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes	PHASE4	UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients	PHASE2	COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma	PHASE2	COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients	PHASE1/PHASE2	COMPLETED
Reverse Transcriptase Inhibitors in AGS	PHASE2	COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS	PHASE2	COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma	PHASE1	COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia	PHASE1	RECRUITING
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	PHASE1	WITHDRAWN
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors	PHASE1	COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors	PHASE1	COMPLETED
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)	nan	RECRUITING
Testing of Micellar Casein, Blended Micellar Casein and Native Whey	nan	COMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)	nan	COMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care	nan	COMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma	nan	COMPLETED
Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation	nan	COMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus	nan	COMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress	nan	WITHDRAWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
RibOSE - Glucose and Resistance Exercise Training	nan	COMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic	nan	COMPLETED
miR-155 Expression in Episodic and Chronic Migraine	nan	UNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact	nan	UNKNOWN
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates	nan	COMPLETED
Protein Intake and Step Reduction in Older Adults	nan	COMPLETED
Quantification of GADD34 Expression in RA	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a RPS29 binder may also engage these)

Protein	Name	Similarity
P62276	—	1.000	P62276 →
P62274	—	1.000	P62274 →
G1U7M4	—	1.000	G1U7M4 →
Q5R9J0	—	1.000	Q5R9J0 →
Q6UZG0	—	1.000	Q6UZG0 →
Q90YP2	—	1.000	Q90YP2 →
P62275	—	1.000	P62275 →
Q6QAP6	—	1.000	Q6QAP6 →
Q757G1	—	1.000	Q757G1 →
Q7XYB0	—	1.000	Q7XYB0 →
Q46GA9	—	0.998	Q46GA9 →
Q98SC7	—	0.998	Q98SC7 →
P41057	—	0.997	P41057 →
Q9C2P2	—	0.997	Q9C2P2 →
L7IM20	—	0.997	L7IM20 →
P0CT15	—	0.997	P0CT15 →
P41058	—	0.996	P41058 →
Q680P8	—	0.996	Q680P8 →
Q97BW2	—	0.995	Q97BW2 →
Q12ZT7	—	0.995	Q12ZT7 →
Q6FWE3	—	0.995	Q6FWE3 →
Q6L1B3	—	0.994	Q6L1B3 →
Q8TRT3	—	0.993	Q8TRT3 →
Q2NFX1	—	0.993	Q2NFX1 →
O74329	—	0.993	O74329 →
Q76P36	—	0.993	Q76P36 →
Q9HIS1	—	0.992	Q9HIS1 →
Q8WQI3	—	0.992	Q8WQI3 →
Q6F473	—	0.992	Q6F473 →
Q97ZQ5	—	0.991	Q97ZQ5 →